Extracellular vesicles‐based theranostics for neurodegenerative diseases
WIREs Nanomedicine and Nanobiotechnology · 2024
DOI: 10.1002/wnan.1993 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift WIREs Nanomedicine and Nanobiotechnology, 2024. Verfasst von Han Zhao und 3 weiteren Autor:innen. Beteiligte Einrichtung: CAS Key Laboratory of Standardization and Measurement for Nanotechnology, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, …. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Extracellular Vesicles, Theranostic Nanomedicine, Blood-Brain Barrier. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 134 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Bureau of Frontier Science and Basic Research, Chinese Academy of Science.
Abstract (Originalsprache)
With the accelerated aging of the global population, the incidence of neurodegenerative diseases (NDDs) is increasing year by year. Because of the presence of the blood–brain barrier (BBB), the low concentration of the biomarkers in peripheral blood and the low penetration rate of the drugs through BBB into brain hinders the development of diagnosis and treatment of NDDs. As an effective mediator to penetrate through BBB in both directions, extracellular vesicles (EVs) have attracted much attention in the early diagnosis and treatment of NDDs because of their superior performance as drug carriers and detection biomarkers. Brain‐derived EVs in body fluids contain disease‐related biomolecules can be used as early diagnostic biomarkers for NDDs. In addition, as one of the subpopulations of EVs, exosomes, especially stem cell‐derived exosomes, have great potential in the treatment of NDDs. The ability to cross the BBB, together with the feasibility of versatile functionalization of EV for NDDs pathogen targeting facilitate EVs a potential tool for targeted drug delivery systems for NDDs. In this review, the important role of EVs in the diagnosis and treatment of NDDs and the current research progress will be discussed. This article is categorized under: Diagnostic Tools > Diagnostic Nanodevices Therapeutic Approaches and Drug Discovery > Nanomedicine for Neurological Disease
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CAS Key Laboratory of Standardization and Measurement for Nanotechnology, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology, Beijing, China.
- University of Chinese Academy of Sciences, Beijing, China.
- CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Key Laboratory of Standardization and Measurement for Nanotechnology, National Center for Nanoscience and Technology, Beijing, China.
ORCID-Profile: Yanlian Yang
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Bureau of Frontier Science and Basic Research, Chinese Academy of Science
Zitieren
APA
Zhao, H., Zhu, L., Wang, C., & Yang, Y. (2024). Extracellular vesicles‐based theranostics for neurodegenerative diseases. WIREs Nanomedicine and Nanobiotechnology. https://doi.org/10.1002/wnan.1993
Vancouver
Zhao H, Zhu L, Wang C, Yang Y. Extracellular vesicles‐based theranostics for neurodegenerative diseases. WIREs Nanomedicine and Nanobiotechnology. 2024. doi:10.1002/wnan.1993
BibTeX
@article{Zhao2024,
author = {Zhao, Han and Zhu, Ling and Wang, Chen and Yang, Yanlian},
title = {Extracellular vesicles‐based theranostics for neurodegenerative diseases},
journal = {WIREs Nanomedicine and Nanobiotechnology},
year = {2024},
doi = {10.1002/wnan.1993}
}
EUVIMED